| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent diacylglycerol kinase activity | 5.58e-06 | 11 | 66 | 3 | GO:0004143 | |
| GeneOntologyMolecularFunction | zinc ion binding | RNF144B ZCCHC4 ATXN7L3 USP45 TRIM61 KDM5A LMCD1 PRICKLE2 ZC3HC1 LHX3 UPF1 ARIH1 TRIM37 | 5.79e-06 | 891 | 66 | 13 | GO:0008270 |
| GeneOntologyMolecularFunction | tRNA-4-demethylwyosine synthase activity | 1.08e-05 | 2 | 66 | 2 | GO:0102521 | |
| GeneOntologyMolecularFunction | osmolarity-sensing monoatomic cation channel activity | 1.07e-04 | 5 | 66 | 2 | GO:1990760 | |
| GeneOntologyMolecularFunction | transition metal ion binding | RNF144B ZCCHC4 ATXN7L3 USP45 TRIM61 KDM5A LMCD1 PRICKLE2 ZC3HC1 LHX3 UPF1 ARIH1 TRIM37 | 1.18e-04 | 1189 | 66 | 13 | GO:0046914 |
| GeneOntologyMolecularFunction | osmosensor activity | 1.60e-04 | 6 | 66 | 2 | GO:0005034 | |
| GeneOntologyMolecularFunction | oxo-acid-lyase activity | 2.24e-04 | 7 | 66 | 2 | GO:0016833 | |
| GeneOntologyMolecularFunction | lipid kinase activity | 3.36e-04 | 41 | 66 | 3 | GO:0001727 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 5.12e-04 | 562 | 66 | 8 | GO:0003712 | |
| GeneOntologyMolecularFunction | calcium ion binding | NID2 NELL2 NOTCH2NLA CRELD2 DGKB LTBP1 NOTCH2NLC LRP1B NOTCH1 | 7.65e-04 | 749 | 66 | 9 | GO:0005509 |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 1.25e-03 | 16 | 66 | 2 | GO:0005041 | |
| GeneOntologyMolecularFunction | FMN binding | 1.25e-03 | 16 | 66 | 2 | GO:0010181 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 2.17e-03 | 21 | 66 | 2 | GO:0030228 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on RNA | 2.53e-03 | 417 | 66 | 6 | GO:0140098 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 2.81e-03 | 85 | 66 | 3 | GO:0038024 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 3.27e-03 | 303 | 66 | 5 | GO:0003713 | |
| GeneOntologyMolecularFunction | molecular function inhibitor activity | 3.46e-03 | 596 | 66 | 7 | GO:0140678 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 3.48e-03 | 188 | 66 | 4 | GO:0005201 | |
| GeneOntologyMolecularFunction | Notch binding | 3.58e-03 | 27 | 66 | 2 | GO:0005112 | |
| GeneOntologyBiologicalProcess | lipid phosphorylation | 5.31e-06 | 11 | 67 | 3 | GO:0046834 | |
| GeneOntologyCellularComponent | ESC/E(Z) complex | 1.89e-05 | 17 | 65 | 3 | GO:0035098 | |
| GeneOntologyCellularComponent | extrinsic component of postsynaptic density membrane | 4.22e-04 | 10 | 65 | 2 | GO:0099147 | |
| GeneOntologyCellularComponent | PcG protein complex | 5.69e-04 | 52 | 65 | 3 | GO:0031519 | |
| GeneOntologyCellularComponent | extrinsic component of postsynaptic specialization membrane | 6.16e-04 | 12 | 65 | 2 | GO:0098892 | |
| Domain | EGF_CA | 6.70e-10 | 86 | 66 | 8 | PF07645 | |
| Domain | EGF_Ca-bd_CS | 1.77e-09 | 97 | 66 | 8 | IPR018097 | |
| Domain | EGF_CA | 2.08e-09 | 99 | 66 | 8 | PS01187 | |
| Domain | ASX_HYDROXYL | 2.26e-09 | 100 | 66 | 8 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 3.60e-09 | 106 | 66 | 8 | IPR000152 | |
| Domain | EGF | NID2 NELL2 BRINP3 NOTCH2NLA CRELD2 LTBP1 TEK NOTCH2NLC LRP1B NOTCH1 | 9.35e-09 | 235 | 66 | 10 | SM00181 |
| Domain | EGF_CA | 1.10e-08 | 122 | 66 | 8 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.25e-08 | 124 | 66 | 8 | IPR001881 | |
| Domain | EGF-like_CS | NID2 NELL2 NOTCH2NLA CRELD2 LTBP1 TEK NOTCH2NLC LRP1B ITGB7 NOTCH1 | 2.54e-08 | 261 | 66 | 10 | IPR013032 |
| Domain | EGF_2 | NID2 NELL2 NOTCH2NLA CRELD2 LTBP1 TEK NOTCH2NLC LRP1B ITGB7 NOTCH1 | 2.93e-08 | 265 | 66 | 10 | PS01186 |
| Domain | Growth_fac_rcpt_ | 7.54e-08 | 156 | 66 | 8 | IPR009030 | |
| Domain | EGF_3 | NID2 NELL2 NOTCH2NLA CRELD2 LTBP1 TEK NOTCH2NLC LRP1B NOTCH1 | 1.35e-07 | 235 | 66 | 9 | PS50026 |
| Domain | LIM | 1.55e-07 | 69 | 66 | 6 | PF00412 | |
| Domain | - | 1.70e-07 | 70 | 66 | 6 | 2.10.110.10 | |
| Domain | Znf_LIM | 1.85e-07 | 71 | 66 | 6 | IPR001781 | |
| Domain | LIM_DOMAIN_1 | 1.85e-07 | 71 | 66 | 6 | PS00478 | |
| Domain | LIM_DOMAIN_2 | 1.85e-07 | 71 | 66 | 6 | PS50023 | |
| Domain | LIM | 1.85e-07 | 71 | 66 | 6 | SM00132 | |
| Domain | EGF-like_dom | NID2 NELL2 NOTCH2NLA CRELD2 LTBP1 TEK NOTCH2NLC LRP1B NOTCH1 | 2.20e-07 | 249 | 66 | 9 | IPR000742 |
| Domain | EGF_1 | NELL2 NOTCH2NLA CRELD2 LTBP1 TEK NOTCH2NLC LRP1B ITGB7 NOTCH1 | 2.69e-07 | 255 | 66 | 9 | PS00022 |
| Domain | EGF_extracell | 2.22e-06 | 60 | 66 | 5 | IPR013111 | |
| Domain | EGF_2 | 2.22e-06 | 60 | 66 | 5 | PF07974 | |
| Domain | DAGK_acc | 4.97e-06 | 10 | 66 | 3 | PF00609 | |
| Domain | Diacylglycerol_kin_accessory | 4.97e-06 | 10 | 66 | 3 | IPR000756 | |
| Domain | DAGKa | 4.97e-06 | 10 | 66 | 3 | SM00045 | |
| Domain | EGF | 5.46e-06 | 126 | 66 | 6 | PF00008 | |
| Domain | tRNA_wybutosine-synth | 1.23e-05 | 2 | 66 | 2 | IPR013917 | |
| Domain | Wyosine_form | 1.23e-05 | 2 | 66 | 2 | PF08608 | |
| Domain | DAGKc | 1.49e-05 | 14 | 66 | 3 | SM00046 | |
| Domain | Diacylglycerol_kinase_cat_dom | 1.86e-05 | 15 | 66 | 3 | IPR001206 | |
| Domain | DAGK_cat | 1.86e-05 | 15 | 66 | 3 | PF00781 | |
| Domain | DAGK | 1.86e-05 | 15 | 66 | 3 | PS50146 | |
| Domain | NAD/diacylglycerol_kinase | 2.77e-05 | 17 | 66 | 3 | IPR016064 | |
| Domain | cEGF | 1.03e-04 | 26 | 66 | 3 | IPR026823 | |
| Domain | cEGF | 1.03e-04 | 26 | 66 | 3 | PF12662 | |
| Domain | PET | 1.83e-04 | 6 | 66 | 2 | PF06297 | |
| Domain | PET_domain | 1.83e-04 | 6 | 66 | 2 | IPR010442 | |
| Domain | PET | 1.83e-04 | 6 | 66 | 2 | PS51303 | |
| Domain | FLAVODOXIN_LIKE | 3.40e-04 | 8 | 66 | 2 | PS50902 | |
| Domain | Flavodoxin/NO_synth | 3.40e-04 | 8 | 66 | 2 | IPR008254 | |
| Domain | Flavdoxin-like | 3.40e-04 | 8 | 66 | 2 | IPR001094 | |
| Domain | Flavodoxin_1 | 3.40e-04 | 8 | 66 | 2 | PF00258 | |
| Domain | rSAM | 4.36e-04 | 9 | 66 | 2 | IPR007197 | |
| Domain | Radical_SAM | 4.36e-04 | 9 | 66 | 2 | PF04055 | |
| Domain | E3_UB_ligase_RBR | 5.43e-04 | 10 | 66 | 2 | IPR031127 | |
| Domain | Flavoprotein-like_dom | 5.43e-04 | 10 | 66 | 2 | IPR029039 | |
| Domain | - | 5.43e-04 | 10 | 66 | 2 | 3.40.50.360 | |
| Domain | - | 1.02e-03 | 449 | 66 | 7 | 3.30.40.10 | |
| Domain | C1_1 | 1.08e-03 | 57 | 66 | 3 | PF00130 | |
| Domain | IBR | 1.09e-03 | 14 | 66 | 2 | SM00647 | |
| Domain | Ldl_recept_b | 1.09e-03 | 14 | 66 | 2 | PF00058 | |
| Domain | LDLRB | 1.09e-03 | 14 | 66 | 2 | PS51120 | |
| Domain | IBR | 1.09e-03 | 14 | 66 | 2 | PF01485 | |
| Domain | Znf_RING/FYVE/PHD | 1.15e-03 | 459 | 66 | 7 | IPR013083 | |
| Domain | IBR_dom | 1.25e-03 | 15 | 66 | 2 | IPR002867 | |
| Domain | LY | 1.25e-03 | 15 | 66 | 2 | SM00135 | |
| Domain | LDLR_classB_rpt | 1.25e-03 | 15 | 66 | 2 | IPR000033 | |
| Domain | ZF_DAG_PE_1 | 1.51e-03 | 64 | 66 | 3 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 1.51e-03 | 64 | 66 | 3 | PS50081 | |
| Domain | C1 | 1.57e-03 | 65 | 66 | 3 | SM00109 | |
| Domain | PE/DAG-bd | 1.65e-03 | 66 | 66 | 3 | IPR002219 | |
| Domain | TNFR_c6 | 2.71e-03 | 22 | 66 | 2 | PF00020 | |
| Domain | TNFR | 3.78e-03 | 26 | 66 | 2 | SM00208 | |
| Domain | TNFR_NGFR_1 | 4.70e-03 | 29 | 66 | 2 | PS00652 | |
| Domain | TNFR_NGFR_2 | 4.70e-03 | 29 | 66 | 2 | PS50050 | |
| Domain | PROTEIN_KINASE_TYR | 4.90e-03 | 97 | 66 | 3 | PS00109 | |
| Domain | Tyr_kinase_AS | 4.90e-03 | 97 | 66 | 3 | IPR008266 | |
| Domain | TNFR/NGFR_Cys_rich_reg | 6.05e-03 | 33 | 66 | 2 | IPR001368 | |
| Pathway | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | 1.15e-04 | 25 | 54 | 3 | MM14511 | |
| Pathway | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | 1.46e-04 | 27 | 54 | 3 | M12123 | |
| Pubmed | KLHL5 USP45 TYW1B TRIM61 DNAAF10 SLFN12 DGKZ TYW1 PEAK1 ABLIM3 WDFY4 TRIM37 | 1.15e-06 | 1084 | 68 | 12 | 11544199 | |
| Pubmed | 1.17e-06 | 11 | 68 | 3 | 17021016 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 16162496 | ||
| Pubmed | Homo- and Heterotypic Association Regulates Signaling by the SgK269/PEAK1 and SgK223 Pseudokinases. | 3.77e-06 | 2 | 68 | 2 | 27531744 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 32700598 | ||
| Pubmed | Structure of SgK223 pseudokinase reveals novel mechanisms of homotypic and heterotypic association. | 3.77e-06 | 2 | 68 | 2 | 29079850 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 25038227 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 9418910 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 12902484 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 22706687 | ||
| Pubmed | Signal peptide prediction based on analysis of experimentally verified cleavage sites. | 1.33e-05 | 264 | 68 | 6 | 15340161 | |
| Pubmed | Effects of Emx2 inactivation on the gene expression profile of neural precursors. | 2.25e-05 | 4 | 68 | 2 | 16420441 | |
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 29561261 | ||
| Pubmed | Notch-modifying xylosyltransferase structures support an SNi-like retaining mechanism. | 2.25e-05 | 4 | 68 | 2 | 26414444 | |
| Pubmed | Evolution of Human Brain Size-Associated NOTCH2NL Genes Proceeds toward Reduced Protein Levels. | 2.25e-05 | 4 | 68 | 2 | 32330268 | |
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 27453008 | ||
| Pubmed | Genomic structure and chromosomal localization of the mouse LIM/homeobox gene Lhx3. | 2.25e-05 | 4 | 68 | 2 | 7665181 | |
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 34562599 | ||
| Pubmed | NOTCH1 Mutations in Aortic Stenosis: Association with Osteoprotegerin/RANK/RANKL. | 2.25e-05 | 4 | 68 | 2 | 28246602 | |
| Pubmed | Ribonucleome analysis identified enzyme genes responsible for wybutosine synthesis. | 2.25e-05 | 4 | 68 | 2 | 17150819 | |
| Pubmed | Diacylglycerol kinase iota regulates Ras guanyl-releasing protein 3 and inhibits Rap1 signaling. | 2.25e-05 | 4 | 68 | 2 | 15894621 | |
| Pubmed | 2.45e-05 | 608 | 68 | 8 | 16713569 | ||
| Pubmed | Linkage mapping of the gene for the LIM-homeoprotein LIM3 (locus Lhx3) to mouse chromosome 2. | 3.75e-05 | 5 | 68 | 2 | 8597642 | |
| Pubmed | Human-Specific NOTCH2NL Genes Affect Notch Signaling and Cortical Neurogenesis. | 3.75e-05 | 5 | 68 | 2 | 29856954 | |
| Pubmed | Human-Specific NOTCH2NL Genes Expand Cortical Neurogenesis through Delta/Notch Regulation. | 3.75e-05 | 5 | 68 | 2 | 29856955 | |
| Pubmed | Biosynthesis of alkyl lysophosphatidic acid by diacylglycerol kinases. | 3.75e-05 | 5 | 68 | 2 | 22627129 | |
| Pubmed | 4.22e-05 | 196 | 68 | 5 | 19334288 | ||
| Pubmed | The mouse kinome: discovery and comparative genomics of all mouse protein kinases. | 5.62e-05 | 6 | 68 | 2 | 15289607 | |
| Pubmed | Association of six CpG-SNPs in the inflammation-related genes with coronary heart disease. | 5.62e-05 | 6 | 68 | 2 | 27461004 | |
| Pubmed | 5.62e-05 | 6 | 68 | 2 | 11046156 | ||
| Pubmed | 5.62e-05 | 6 | 68 | 2 | 24829201 | ||
| Pubmed | A directed protein interaction network for investigating intracellular signal transduction. | 6.34e-05 | 1124 | 68 | 10 | 21900206 | |
| Pubmed | Early embryonic expression patterns of the mouse Flamingo and Prickle orthologues. | 7.86e-05 | 7 | 68 | 2 | 17937400 | |
| Pubmed | 1.05e-04 | 8 | 68 | 2 | 20144788 | ||
| Pubmed | Generation of a transcription map at the HSD17B locus centromeric to BRCA1 at 17q21. | 1.34e-04 | 9 | 68 | 2 | 7490091 | |
| Pubmed | Genetic nomenclature for loci controlling surface antigens of mouse hemopoietic cells. | 1.56e-04 | 53 | 68 | 3 | 1431091 | |
| Pubmed | 1.68e-04 | 10 | 68 | 2 | 17728344 | ||
| Pubmed | 2.05e-04 | 11 | 68 | 2 | 22438827 | ||
| Pubmed | Suppression of Notch signalling by the COUP-TFII transcription factor regulates vein identity. | 2.05e-04 | 11 | 68 | 2 | 15875024 | |
| Pubmed | 2.05e-04 | 11 | 68 | 2 | 20346184 | ||
| Pubmed | 2.15e-04 | 59 | 68 | 3 | 21421844 | ||
| Pubmed | 2.45e-04 | 12 | 68 | 2 | 18799150 | ||
| Pubmed | Attenuated Wnt signaling perturbs pancreatic growth but not pancreatic function. | 2.45e-04 | 12 | 68 | 2 | 16186384 | |
| Pubmed | 2.45e-04 | 12 | 68 | 2 | 35192416 | ||
| Pubmed | 2.90e-04 | 13 | 68 | 2 | 37317851 | ||
| Pubmed | The SRF target gene Fhl2 antagonizes RhoA/MAL-dependent activation of SRF. | 3.38e-04 | 14 | 68 | 2 | 15610731 | |
| Pubmed | Notch and MAML signaling drives Scl-dependent interneuron diversity in the spinal cord. | 3.38e-04 | 14 | 68 | 2 | 17359917 | |
| Pubmed | Myocardium-derived angiopoietin-1 is essential for coronary vein formation in the developing heart. | 3.89e-04 | 15 | 68 | 2 | 25072663 | |
| Pubmed | FBXO45-MYCBP2 regulates mitotic cell fate by targeting FBXW7 for degradation. | 3.89e-04 | 15 | 68 | 2 | 31285543 | |
| Pubmed | 3.89e-04 | 15 | 68 | 2 | 22962329 | ||
| Pubmed | 4.44e-04 | 16 | 68 | 2 | 19619491 | ||
| Pubmed | A diverse family of proteins containing tumor necrosis factor receptor-associated factor domains. | 4.44e-04 | 16 | 68 | 2 | 11279055 | |
| Pubmed | 4.44e-04 | 16 | 68 | 2 | 32937136 | ||
| Pubmed | Physiological notch signaling maintains bone homeostasis via RBPjk and Hey upstream of NFATc1. | 5.03e-04 | 17 | 68 | 2 | 22457635 | |
| Pubmed | 5.03e-04 | 17 | 68 | 2 | 21531785 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | 5.36e-04 | 1201 | 68 | 9 | 35696571 | |
| Pubmed | Epithelial Notch signaling regulates lung alveolar morphogenesis and airway epithelial integrity. | 5.65e-04 | 18 | 68 | 2 | 27364009 | |
| Pubmed | Jumonji modulates polycomb activity and self-renewal versus differentiation of stem cells. | 5.65e-04 | 18 | 68 | 2 | 20064376 | |
| Pubmed | 6.30e-04 | 19 | 68 | 2 | 18505817 | ||
| Pubmed | 6.30e-04 | 19 | 68 | 2 | 18206867 | ||
| Pubmed | 6.30e-04 | 19 | 68 | 2 | 20627076 | ||
| Pubmed | Transcriptional fates of human-specific segmental duplications in brain. | 6.30e-04 | 19 | 68 | 2 | 30228200 | |
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | 7.15e-04 | 361 | 68 | 5 | 30344098 | |
| Pubmed | 7.72e-04 | 21 | 68 | 2 | 19806668 | ||
| Pubmed | 7.72e-04 | 21 | 68 | 2 | 26939553 | ||
| Pubmed | 7.72e-04 | 21 | 68 | 2 | 18617694 | ||
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | 7.98e-04 | 560 | 68 | 6 | 21653829 | |
| Pubmed | 8.48e-04 | 22 | 68 | 2 | 15301860 | ||
| Pubmed | 8.48e-04 | 22 | 68 | 2 | 22366192 | ||
| Pubmed | Involvement of Wnt, Eda and Shh at defined stages of sweat gland development. | 8.48e-04 | 22 | 68 | 2 | 25249463 | |
| Pubmed | Motor neurons with axial muscle projections specified by Wnt4/5 signaling. | 8.48e-04 | 22 | 68 | 2 | 19285468 | |
| Pubmed | 9.28e-04 | 23 | 68 | 2 | 30779601 | ||
| Pubmed | 9.28e-04 | 23 | 68 | 2 | 20932654 | ||
| Pubmed | 9.28e-04 | 23 | 68 | 2 | 18297083 | ||
| Pubmed | 9.28e-04 | 23 | 68 | 2 | 33315499 | ||
| Pubmed | 9.28e-04 | 23 | 68 | 2 | 8799160 | ||
| Pubmed | 1.01e-03 | 24 | 68 | 2 | 20371769 | ||
| Pubmed | 1.01e-03 | 24 | 68 | 2 | 21633169 | ||
| Pubmed | Endothelial cell-derived GABA signaling modulates neuronal migration and postnatal behavior. | 1.01e-03 | 24 | 68 | 2 | 29086765 | |
| Pubmed | 1.01e-03 | 24 | 68 | 2 | 21149574 | ||
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 1.04e-03 | 101 | 68 | 3 | 23382219 | |
| Pubmed | Proteomics characterization of extracellular space components in the human aorta. | 1.04e-03 | 101 | 68 | 3 | 20551380 | |
| Pubmed | Single Cell and Open Chromatin Analysis Reveals Molecular Origin of Epidermal Cells of the Skin. | 1.10e-03 | 25 | 68 | 2 | 30220568 | |
| Pubmed | 1.19e-03 | 26 | 68 | 2 | 14960276 | ||
| Pubmed | 1.19e-03 | 26 | 68 | 2 | 20978081 | ||
| Pubmed | 1.19e-03 | 26 | 68 | 2 | 23988635 | ||
| Pubmed | 1.28e-03 | 27 | 68 | 2 | 20490451 | ||
| Pubmed | Conditionals by inversion provide a universal method for the generation of conditional alleles. | 1.28e-03 | 27 | 68 | 2 | 23918385 | |
| Pubmed | Reconstruction of phrenic neuron identity in embryonic stem cell-derived motor neurons. | 1.28e-03 | 27 | 68 | 2 | 24496616 | |
| Pubmed | 1.38e-03 | 28 | 68 | 2 | 12471243 | ||
| Pubmed | 1.38e-03 | 28 | 68 | 2 | 35297995 | ||
| Pubmed | 1.38e-03 | 28 | 68 | 2 | 34963058 | ||
| Pubmed | Extra-embryonic vasculature development is regulated by the transcription factor HAND1. | 1.38e-03 | 28 | 68 | 2 | 15073150 | |
| Pubmed | 1.48e-03 | 29 | 68 | 2 | 17573777 | ||
| Pubmed | Dosage-dependent requirement for mouse Vezf1 in vascular system development. | 1.48e-03 | 29 | 68 | 2 | 15882861 | |
| Pubmed | 1.48e-03 | 29 | 68 | 2 | 24105743 | ||
| Pubmed | 1.55e-03 | 430 | 68 | 5 | 32581705 | ||
| Pubmed | 1.58e-03 | 30 | 68 | 2 | 15880404 | ||
| Pubmed | Suppression of epithelial differentiation by Foxi3 is essential for molar crown patterning. | 1.58e-03 | 30 | 68 | 2 | 26450968 | |
| Pubmed | GDE2 regulates subtype-specific motor neuron generation through inhibition of Notch signaling. | 1.58e-03 | 30 | 68 | 2 | 21943603 | |
| Interaction | ZFP41 interactions | 1.10e-06 | 57 | 65 | 5 | int:ZFP41 | |
| GeneFamily | LIM domain containing | 3.85e-07 | 59 | 46 | 5 | 1218 | |
| GeneFamily | EF-hand domain containing|Diacylglycerol kinases | 1.83e-06 | 10 | 46 | 3 | 1178 | |
| GeneFamily | Low density lipoprotein receptors | 4.85e-04 | 13 | 46 | 2 | 634 | |
| GeneFamily | CD molecules|Tumor necrosis factor receptor superfamily|Death inducing signaling complex | 2.46e-03 | 29 | 46 | 2 | 782 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_DN | 4.31e-06 | 491 | 67 | 9 | MM455 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2B | 1.60e-05 | 439 | 67 | 8 | M39054 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL1 | 4.00e-05 | 364 | 67 | 7 | M39057 | |
| Coexpression | ONDER_CDH1_TARGETS_2_UP | 5.07e-05 | 257 | 67 | 6 | M13867 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBGABA | ADORA2A-AS1 ANOS1 BRINP3 SCN7A PRICKLE2 ABLIM3 WDFY4 LRP1B FRMD3 | 7.28e-05 | 703 | 67 | 9 | M39070 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HENDO | RNF144B NID2 ADORA2A-AS1 KLHL5 LMCD1 SLCO1A2 PRICKLE2 PEAK1 TEK ABLIM3 | 8.17e-05 | 888 | 67 | 10 | M39049 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.31e-04 | 191 | 67 | 5 | MM17059 | |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_1 | 1.31e-04 | 440 | 67 | 7 | M39039 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2A | 1.43e-04 | 600 | 67 | 8 | M39055 | |
| Coexpression | GSE22611_NOD2_TRANSD_VS_CTRL_TRANSD_HEK293_MDP_STIM_2H_UP | 1.47e-04 | 196 | 67 | 5 | M8161 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.47e-04 | 196 | 67 | 5 | M3008 | |
| Coexpression | GSE46242_CTRL_VS_EGR2_DELETED_ANERGIC_TH1_CD4_TCELL_UP | 1.47e-04 | 196 | 67 | 5 | M9707 | |
| Coexpression | GSE25088_CTRL_VS_IL4_STIM_MACROPHAGE_DN | 1.62e-04 | 200 | 67 | 5 | M8007 | |
| Coexpression | GSE7460_FOXP3_MUT_VS_WT_ACT_WITH_TGFB_TCONV_UP | 1.62e-04 | 200 | 67 | 5 | M5703 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.82e-07 | 184 | 68 | 6 | 54e5b63f55b8d6eccad53d389ea9c78f991e1414 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes-Fibromyocytes_L.2.3.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.82e-07 | 184 | 68 | 6 | 7b5678718719020b52e7c2a7bd9797987defd7ff | |
| ToppCell | facs-Trachea-18m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.47e-07 | 189 | 68 | 6 | ecbe079606406f47d4fc97fe1670790dda8e10de | |
| ToppCell | facs-Trachea-18m-Endothelial-endothelial_cell_of_trachea|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.47e-07 | 189 | 68 | 6 | e830fa0ddc3dccfaf9e88e8c416ed6aab12e3e3f | |
| ToppCell | facs-Trachea-18m-Endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.47e-07 | 189 | 68 | 6 | f635f3f13bced3bcf796cf55723a2df851f973fe | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.06e-07 | 193 | 68 | 6 | 0f19b6384659a5bcc11b45dc2df8454b96ddf4cd | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.06e-07 | 193 | 68 | 6 | a586727dc23b0777770f54fc8d4fe5f30b68439f | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.54e-07 | 196 | 68 | 6 | 9830fb3da7a60f65ad463e9054bb77c06b025e4d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.70e-07 | 197 | 68 | 6 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.70e-07 | 197 | 68 | 6 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.70e-07 | 197 | 68 | 6 | ac4f53acb2f8a428b0f2fab3c30a34e095a1bed7 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.87e-07 | 198 | 68 | 6 | 22e766df1276c5b14aa0d83f434f47140ebb98ea | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.05e-07 | 199 | 68 | 6 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.23e-07 | 200 | 68 | 6 | a66449b22b39dd6987fc2c3ed160d24564234ced | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.62e-06 | 152 | 68 | 5 | 621e9b33cd3bb1c7b7d0633069f286b203e3d9c0 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_B-ABC_aged-B_naive|lymph-node_spleen / Manually curated celltypes from each tissue | 5.89e-06 | 168 | 68 | 5 | 494d5a11154ff22fedb25f4036d730cef376da60 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-Smooth_muscle_cells|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 7.19e-06 | 175 | 68 | 5 | fed9e4120c758fdcc23bb248d1801002b0e0d485 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive-B_naive-11|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.59e-06 | 177 | 68 | 5 | 3535575686c9700ab72700aae6f2070ebbb50044 | |
| ToppCell | facs-GAT-Fat-18m-Endothelial|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.02e-06 | 179 | 68 | 5 | d56fa2a0b119d51a8d41b00fbbd7dfddefeb279c | |
| ToppCell | facs-GAT-Fat-18m-Endothelial-endothelial_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.02e-06 | 179 | 68 | 5 | e0542694fa79d67f67be6f85b4fa6d18f7523253 | |
| ToppCell | facs-GAT-Fat-18m-Endothelial-nan|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.02e-06 | 179 | 68 | 5 | 83343b68977969c7978acd930a66fc7c44df6a15 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.46e-06 | 181 | 68 | 5 | 451b87ac95154bb80018b8dd245b4a6389d81411 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.46e-06 | 181 | 68 | 5 | 9c157de9d3403e092c907599f2a2c16db5b21131 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.46e-06 | 181 | 68 | 5 | eea943fdcbef0bbaa8578f3296923e874893b405 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.46e-06 | 181 | 68 | 5 | 6956ecd6264f7469a25e555673bce4eb97d28f7a | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.69e-06 | 182 | 68 | 5 | e3248d108b51c49ca2c978636e13017e23b53860 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.93e-06 | 183 | 68 | 5 | bc7dd6a40ec9c773d005c1a46f305d40cdd0a326 | |
| ToppCell | LV-07._Pericyte|World / Chamber and Cluster_Paper | 8.93e-06 | 183 | 68 | 5 | 273db6a3b00a93ca852498471187b642b5368185 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 9.17e-06 | 184 | 68 | 5 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | droplet-Heart-nan-18m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.41e-06 | 185 | 68 | 5 | a32d5cb596ebac80eb1ac301055e65d420879ec8 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.91e-06 | 187 | 68 | 5 | c104fbfef2d0bef64077ac721edf2379fd59d547 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 9.91e-06 | 187 | 68 | 5 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | normal_Lung-Fibroblasts-Smooth_muscle_cells|normal_Lung / Location, Cell class and cell subclass | 1.02e-05 | 188 | 68 | 5 | fd70fb89570f014d1299c60fe017dc09f24e57c6 | |
| ToppCell | severe_influenza-Platelet|World / disease group, cell group and cell class (v2) | 1.02e-05 | 188 | 68 | 5 | b54632baa682aaf51100d44e7f114a54d5edd695 | |
| ToppCell | facs-Trachea-nan-3m-Endothelial|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-05 | 189 | 68 | 5 | f60ac60ab9b317a0196f0cbbe520ef7dbd19ac11 | |
| ToppCell | facs-Trachea-nan-18m-Endothelial-endothelial_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-05 | 189 | 68 | 5 | 100eda87ac9c38dddcfa58408b057867a1738acb | |
| ToppCell | COVID-19-Heart-EC_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.04e-05 | 189 | 68 | 5 | fe49852ba15f948b384d6b4c258927c70b741357 | |
| ToppCell | facs-Lung-3m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.04e-05 | 189 | 68 | 5 | 16e019fd6e2376110b767739754389891f391669 | |
| ToppCell | facs-Trachea-nan-18m-Endothelial|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-05 | 189 | 68 | 5 | 5ced78f4b5c276b1bab24df807c00cf5ac8ed3d4 | |
| ToppCell | facs-Trachea-nan-3m-Endothelial-endothelial_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-05 | 189 | 68 | 5 | e3d65417997bdd3f9c312c0977dceb6eca061029 | |
| ToppCell | facs-Trachea-nan-18m-Endothelial-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-05 | 189 | 68 | 5 | 2105d8b011b93a460237e00bc029efd7762dc8d5 | |
| ToppCell | facs-Trachea-nan-3m-Endothelial-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-05 | 189 | 68 | 5 | 5559af03d9d612bb8dcf825e45744a9f8332bac8 | |
| ToppCell | facs-GAT-Fat-24m-Endothelial-nan|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-05 | 190 | 68 | 5 | da2fcd4a2cc6e45c8174109d892f1424e39919a1 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-05 | 190 | 68 | 5 | b855b8b7d3439023390ca44629c1a99f5d4c6801 | |
| ToppCell | facs-Lung-3m-Endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.07e-05 | 190 | 68 | 5 | d55b3ad4d1ec172b042bc08127506c354f87f69d | |
| ToppCell | facs-GAT-Fat-24m-Endothelial|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-05 | 190 | 68 | 5 | 3395b2ff6ffadf84cdb1b5a37a5b6be05b56c30f | |
| ToppCell | facs-SCAT-Fat-18m-Endothelial-nan|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-05 | 190 | 68 | 5 | b0c9dae8189d407c94964c6bfe3ef92035245357 | |
| ToppCell | facs-SCAT-Fat-18m-Endothelial|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-05 | 190 | 68 | 5 | ee63dc04e91ad49aa7820c98e97261176ecebaa6 | |
| ToppCell | facs-GAT-Fat-24m-Endothelial-endothelial_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-05 | 190 | 68 | 5 | e584eaccbc22aa7f7a4340ed8a2a8b45ddca93f4 | |
| ToppCell | facs-SCAT-Fat-18m-Endothelial-endothelial_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-05 | 190 | 68 | 5 | 0e50808bfc3d0820524c8470ae3e8250819d65b2 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes-Fibromyocytes_L.2.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.10e-05 | 191 | 68 | 5 | d35692c652977500a3c36aa26c347a072b71e441 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.10e-05 | 191 | 68 | 5 | 2a107e9096eb58b81b3da61547904d85754f6b2f | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.13e-05 | 192 | 68 | 5 | 72881b280a415e65f87a80ca1369cbb0b722a0c4 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-05 | 192 | 68 | 5 | 4bab9754cfd8b9c2d7cc1490e8a29f58c3c26f6c | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.13e-05 | 192 | 68 | 5 | 2143e1fad2e88b90d668e12af37b2092d379090f | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.13e-05 | 192 | 68 | 5 | 517bc24b9ad5e2b5a3609ca55d7327c4700db9db | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-05 | 193 | 68 | 5 | 2218833749576ba1a0fc95bd155c781e7e1163c6 | |
| ToppCell | facs-Lung-24m-Endothelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.15e-05 | 193 | 68 | 5 | e10ef60a82f182680955a775adc6659325e92310 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-05 | 193 | 68 | 5 | 0f2167eef8203a5659c8c72e4e77646003d64797 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 1.15e-05 | 193 | 68 | 5 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | facs-Lung-18m-Endothelial-capillary_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.15e-05 | 193 | 68 | 5 | ee4b31d9c92f8fd0d3ddb5e723b82300fcb459d1 | |
| ToppCell | facs-Lung-18m-Endothelial-capillary_endothelial-capillary_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.15e-05 | 193 | 68 | 5 | 7401e276b644b254c692160d0e7417ec28d50aa4 | |
| ToppCell | RV-09._Endothelium_I|World / Chamber and Cluster_Paper | 1.15e-05 | 193 | 68 | 5 | e3fa47e2c7cd8a5b69186711c57751f2296de8ae | |
| ToppCell | RV-09._Endothelium_I|RV / Chamber and Cluster_Paper | 1.18e-05 | 194 | 68 | 5 | 7b408096e717f2327c12aea35a8d5fc4621d3b06 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-05 | 194 | 68 | 5 | f159ef8541d75a4e98468947f231bb463bec922c | |
| ToppCell | COVID-19-Heart-EC_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.21e-05 | 195 | 68 | 5 | 50a193475db1bb1e05b8590225a553688c372c14 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.24e-05 | 196 | 68 | 5 | 5159d8625d80c20eb28157b2603c8bde9d377a35 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes-Fibromyocytes_L.2.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.24e-05 | 196 | 68 | 5 | 6b5b7dbcb2cce8a736e44145a01290905876a5e9 | |
| ToppCell | LV-09._Endothelium_I|LV / Chamber and Cluster_Paper | 1.27e-05 | 197 | 68 | 5 | f9731d4d636e51b94a96805eee6afe9aedc175e3 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.31e-05 | 198 | 68 | 5 | d1827e3707b929e3a3562989a0c11537d344e164 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.31e-05 | 198 | 68 | 5 | c12e7511628db819a52959bb68580e27c00c2e41 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.31e-05 | 198 | 68 | 5 | e9f434bfd072e590fe44d518057ee5aa653038f3 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-K_(Pericytes)|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.31e-05 | 198 | 68 | 5 | c82a151f9f1477d4a401457173b8d72af776c137 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-K_(Pericytes)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.31e-05 | 198 | 68 | 5 | dc63b56bb6291e527b172d603569376286262845 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.31e-05 | 198 | 68 | 5 | aae663c6da70b6e716edeed50cc7d3962d78e697 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 1.34e-05 | 199 | 68 | 5 | fde2b65afde69f402f1b7b056eaa266e9fd5b227 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Dendritic_cell-DC_activated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.34e-05 | 199 | 68 | 5 | 3b2bd3caf4d189a1726a737b0121860b265eec04 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.34e-05 | 199 | 68 | 5 | b1753474152b82a0b811b9878c890a359e14919a | |
| ToppCell | proximal-3-mesenchymal|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.37e-05 | 200 | 68 | 5 | 94250991f78ea56810412d00a4bb645eb975478c | |
| ToppCell | cellseq-Mesenchymal|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.37e-05 | 200 | 68 | 5 | 238285fc372ce2e5e4341fc3084a3a833bf4a0a6 | |
| ToppCell | proximal-mesenchymal|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.37e-05 | 200 | 68 | 5 | 29f3a5c85404c6537d6405d599ebae281e0d4d4f | |
| ToppCell | distal-3-mesenchymal|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.37e-05 | 200 | 68 | 5 | 7a79a2de78325d4f1c4535969106a0a44249028c | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-05 | 200 | 68 | 5 | 3dd022e974fec7013ba18f333da63f58fbf2dd7c | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Fibroblastic-Fibro_alveolar|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-05 | 200 | 68 | 5 | fda92cb28de99a9c4fe83b7db8145a4beafb0826 | |
| ToppCell | PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_5|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.78e-05 | 123 | 68 | 4 | 064e272ee307af0b3f85bb8bafe7f0195ddc3d52 | |
| ToppCell | PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_5|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.78e-05 | 123 | 68 | 4 | 977d91f95c63996cbc1eb9280e12bb55c8b452c8 | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_smooth_muscle-like|E16.5-samps / Age Group, Lineage, Cell class and subclass | 4.98e-05 | 132 | 68 | 4 | 9633653dba1edee47d915212fb6e68426da49de5 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.76e-05 | 137 | 68 | 4 | 0aa4e14b32da0cda677cc0ed6ae470f6ecd77bea | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-MyoFB-3|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 6.44e-05 | 141 | 68 | 4 | 7ae8ead02e5aeb4106c4a30c08a7a061da3a5d6a | |
| ToppCell | frontal_cortex|World / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.62e-05 | 152 | 68 | 4 | f9c29d4568402ca07a717dbffb3ccc7f35c5fe56 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Dendritic-conventional_dendritic_cell-DC_c1-CLEC9A|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.30e-05 | 155 | 68 | 4 | d76a0f99ec35560d18820f9c92b69364ef2250e3 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.53e-05 | 156 | 68 | 4 | 1928c86deb3bcd01db4ae76919a351066aadb39a | |
| ToppCell | Adult-Mesenchymal-myofibroblast_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.00e-04 | 158 | 68 | 4 | 410fa08c9d880d27e80ec939fa5ba5a41dcb31ab | |
| ToppCell | TCGA-Lung-Solid_Tissue_Normal|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.21e-04 | 166 | 68 | 4 | a8ebdd3cb7f59b3feeaacda45ce6d40d10db556f | |
| ToppCell | TCGA-Lung-Solid_Tissue_Normal-Lung|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.21e-04 | 166 | 68 | 4 | c64971c27cb445dffc5a636d4b6a60261b93a2db | |
| ToppCell | TCGA-Lung-Solid_Tissue_Normal-Lung-Lung_normal_tissue|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.21e-04 | 166 | 68 | 4 | 2f3072a7af048f184d33065fdd36153fd563155a | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.21e-04 | 166 | 68 | 4 | 94636dbc039f794c735960c3425e00bdd5523602 | |
| ToppCell | TCGA-Lung-Solid_Tissue_Normal-Lung-Lung_normal_tissue-6|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.21e-04 | 166 | 68 | 4 | 188f2575511f418216874aed9118aa6f165252cb | |
| ToppCell | Adult-Mesenchymal-myofibroblast_cell|Adult / Lineage, Cell type, age group and donor | 1.24e-04 | 167 | 68 | 4 | d584a8548a5317bd9686b3be8246ae6ed568796b | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-B_cells-LZ_GC_cell|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.27e-04 | 168 | 68 | 4 | 08eb1284f9b8bd3e0e4b21bfc2bbee01d35a0bd7 | |
| Drug | Cephalexin monohydrate [23325-78-2]; Down 200; 11uM; MCF7; HT_HG-U133A | 1.83e-06 | 197 | 67 | 7 | 5250_DN | |
| Drug | AC1L4Q08 | 1.08e-05 | 15 | 67 | 3 | CID000161747 | |
| Drug | Nafronyl oxalate [3200-06-4]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 2.36e-05 | 195 | 67 | 6 | 2622_DN | |
| Drug | Cefotaxime sodium salt [64485-93-4]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 2.50e-05 | 197 | 67 | 6 | 2235_DN | |
| Drug | Trimetazidine dihydrochloride [13171-25-0]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 2.57e-05 | 198 | 67 | 6 | 5479_UP | |
| Disease | coronary stenosis (is_marker_for) | 1.39e-05 | 3 | 64 | 2 | DOID:4248 (is_marker_for) | |
| Disease | Oculopharyngodistal myopathy | 1.39e-05 | 3 | 64 | 2 | cv:C1834014 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 5.16e-05 | 447 | 64 | 7 | EFO_0000694, MONDO_0100096 | |
| Disease | trauma exposure measurement | 5.39e-04 | 172 | 64 | 4 | EFO_0010703 | |
| Disease | migraine disorder, endometriosis | 5.43e-04 | 73 | 64 | 3 | EFO_0001065, MONDO_0005277 | |
| Disease | Carcinoma of bladder | 6.93e-04 | 18 | 64 | 2 | C0699885 | |
| Disease | cerebral infarction (is_marker_for) | 7.73e-04 | 19 | 64 | 2 | DOID:3526 (is_marker_for) | |
| Disease | lower face morphology measurement | 1.73e-03 | 109 | 64 | 3 | EFO_0010948 | |
| Disease | Mental deterioration | 1.81e-03 | 29 | 64 | 2 | HP_0001268 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ALDKQWHVSCFKCQT | 166 | O94929 | |
| WHVSCFKCQTCSVIL | 171 | O94929 | |
| FICKENDCWCHCGPK | 271 | Q76B58 | |
| CFPWSTCQAAIHKVC | 121 | P86434 | |
| CTQAWCKFHEILCSF | 111 | Q8IYT2 | |
| TCCPSGWIMHQKSCF | 231 | P21854 | |
| CVCCKIWNHPDVLYE | 616 | Q9Y4B4 | |
| KSCWTVACQKCHKVL | 681 | Q96F81 | |
| FNQWKSKECVCPNCS | 76 | Q14CW9 | |
| MLQCCKCKQWFHEAC | 216 | Q9Y483 | |
| KECQWTDACLSHPCA | 101 | Q7Z3S9 | |
| SACVFSWIEEHCKPQ | 266 | Q9UH92 | |
| PSCHLKFCSCCKDAW | 146 | Q7Z419 | |
| KFCSCCKDAWHAEVS | 151 | Q7Z419 | |
| WIAANTKECPKCHVT | 336 | Q9Y4X5 | |
| WCQNHKQCSKCLEPC | 76 | P23352 | |
| CQNLVHWCDSSPCKN | 1056 | P46531 | |
| FHCKNNRCVFESWVC | 456 | Q9Y561 | |
| ACSAQKCISKHWICD | 2726 | Q9NZR2 | |
| SWIKHGTECTLCQCK | 786 | Q99435 | |
| HCDSFTKRCICDPFW | 896 | Q8IZA0 | |
| VFDCKWVPCSAKFVT | 21 | Q96MX6 | |
| FCKCWTCFKEVDAEQ | 301 | Q9P1W3 | |
| HLTKQLCCCSVGKAW | 696 | Q14766 | |
| TFTEHVWKPGECKNC | 6 | Q9H792 | |
| VDPCHKFTWCLDACI | 256 | Q8WX92 | |
| WHSKCLKCSDCHTPL | 51 | Q9UBR4 | |
| QCSPWKKNACCTAST | 56 | P41439 | |
| CLKSVECFDPHTNKW | 621 | Q96PQ7 | |
| ECFDPHTNKWTLCAQ | 626 | Q96PQ7 | |
| KECQWTDACLSHPCA | 101 | P0DPK4 | |
| QCELCKDWFHNSCVP | 1176 | P29375 | |
| HSWRKICKSCKCSQE | 41 | Q9NZU5 | |
| KQWHPTCFVCAKCSE | 266 | Q9NZU5 | |
| CQKCILSHPSCAWCK | 51 | P26010 | |
| PLQCHGKSDFCWCVD | 1051 | Q14112 | |
| WHATETCFCCAHCKK | 276 | Q7Z3G6 | |
| PACVVYCNTSKKWFC | 131 | Q92900 | |
| VWHKDCFTCSNCKQV | 121 | Q13642 | |
| WHADCFVCVTCSKKL | 181 | Q13642 | |
| FHTSTPAACKHLWKC | 286 | A2A2Y4 | |
| TFCDQLWHKECFLCS | 176 | Q5TD97 | |
| CEVPLHWVCKKCPFA | 176 | Q96E93 | |
| CCARHFWTKICKPVL | 156 | Q9UBT3 | |
| CSWCKQAFHNKVTCF | 286 | O75912 | |
| YWVEGNCPTKCDKCH | 311 | Q9Y6T7 | |
| CHGKPWKCYEEEQCV | 136 | Q6UX82 | |
| CQKTCWEPASCQKSC | 51 | Q3LI77 | |
| SCSWCKQAYHSKVSC | 206 | Q13574 | |
| FEWFCVKTLKVCCSP | 116 | Q6UXH1 | |
| VKENVSGQCCPTWHC | 2061 | Q3ZCN5 | |
| GYCSSHWCCKKEVQE | 851 | Q9P2B2 | |
| KLSVFCWTCKKCICH | 101 | O94972 | |
| FADCNVDCNCPSKIW | 436 | P46721 | |
| KALCTAHEKFCFWPD | 146 | Q86WB0 | |
| CGHNFCLSCIIMSWK | 31 | Q5EBN2 | |
| VWQCNCKFHWCCFVK | 321 | P56706 | |
| KQHCTAKWKTVCAPC | 51 | O00300 | |
| CKCQYKHIVDWCGCS | 561 | Q86Y38 | |
| WAHEGVKPFKCSLCE | 901 | Q9P243 | |
| WCYECDEKLSTHCNK | 126 | Q70EL2 | |
| ASEHWDCKVVSCKNC | 591 | Q92800 | |
| TCLREHSCCFWKEPT | 226 | Q6ZS81 | |
| HSCCFWKEPTFCVLR | 231 | Q6ZS81 | |
| CCAVFAKEPDSWHVK | 311 | Q8IYM2 | |
| CEAQKWGPECNHLCT | 211 | Q02763 | |
| VEHIWKPGSCKNCFC | 21 | Q86YV5 | |
| KCVKPSWIHCSICNH | 416 | Q9H5U6 | |
| PTLCTQKKSWKCNEC | 146 | Q8TBZ5 | |
| TCCKIVENNWFKCFI | 926 | Q01118 | |
| CANKCVFCWRHHTNP | 416 | Q9NV66 | |
| SAFEKCHPWTSCETK | 156 | P25942 | |
| TTPSLACANKCVFCW | 346 | Q6NUM6 | |
| NECKECWKAFVHCSQ | 246 | Q8TAF7 |